Recent News

• 03.11.2025 - Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 03.06.2025 - Marshall Fordyce
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 02.27.2025 - Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
• 02.26.2025 - Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
• 02.13.2025 - Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
• 01.30.2025 - Paul Choi

Recent Filings

• 02.28.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 02.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.26.2025 - EX-99.1 EX-99.1
• 02.26.2025 - 144 Report of proposed sale of securities
• 02.26.2025 - 8-K Current report
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.20.2025 - 4 Statement of changes in beneficial ownership of securities